INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?

Lewy body diseases (LBD) include Parkinson's disease (PD) and dementia with Lewy bodies (DLB) and together with Alzheimer's disease (AD) they show an important neuropathological and clinical overlap. The human alpha- and beta-synuclein genes (SNCA and SNCB) are key factors for the development of Lewy body diseases. Here, we aimed to analyze the genotype distribution of potentially functional SNPs in SNCA and SNCB, perform haplotype analysis for SNCB, and to identify functional insertion and deletion (INDEL) variations within the regulatory region of SNCB which might be responsible for the drastically diminished beta-synuclein levels reported for pure DLB. Thus, we genotyped brain samples from AD, DLB, PD, and healthy controls for two SNCA and four SNCB SNPs. We also analyzed INDEL variations upstream of SNCB, determined SNCB expression levels, and correlated INDEL lengths with expression levels. Applying Fisher's exact, chi-square, ANOVA tests, and the ΔΔCt method, we found disease-specific genotype distribution of SNCA and SNCB SNPs. Additionally, we identified three INDEL variations upstream of SNCB and showed that the INDEL allele lengths were associated with SNCB expression levels. INDEL alleles associated with low SNCB expression were accumulated in pure DLB. Finally, one major and four minor DLB specific SNCB haplotypes were identified with Haploview and Arlequin. In summary, our study showed that different SNCA and SNCB genotypes are associated with the development of either PD or DLB, and that the frequencies of genotypes associated with low SNCB expression are elevated in DLB.

[1]  R. Nussbaum.  Genetics of Synucleinopathies. , 2018, Cold Spring Harbor perspectives in medicine.

[2]  D. Galasko.  Lewy Body Disorders. , 2017, Neurologic clinics.

[3]  M. Montico,et al.  SNCA 3′UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder , 2017, Neurological Sciences.

[4]  Alexander K. Buell,et al.  β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces , 2016, Scientific Reports.

[5]  M. Ingelsson.  Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders , 2016, Front. Neurosci..

[6]  Ekaterina Nosova,et al.  α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease , 2016, Annals of neurology.

[7]  Yonatan Stelzer,et al.  Parkinson-associated risk variant in enhancer element produces subtle effect on target gene expression , 2016, Nature.

[8]  A. Roses,et al.  A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression , 2015, Alzheimer's & Dementia.

[9]  Andrei L. Turinsky,et al.  The missing indels: an estimate of indel variation in a human genome and analysis of factors that impede detection , 2015, Nucleic acids research.

[10]  Jinrong Zhao,et al.  Alpha‐synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta‐analysis , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  Josephine A. Wright,et al.  Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level , 2013, Molecular and Cellular Neuroscience.

[12]  M. Farrer,et al.  SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study , 2011, European journal of neurology.

[13]  O. Combarros,et al.  Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  Ryan E. Mills,et al.  Natural genetic variation caused by small insertions and deletions in the human genome. , 2011, Genome research.

[15]  Sebastian M. Armasu,et al.  Common variants in PARK loci and related genes and Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[16]  E. Tolosa,et al.  The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies. , 2010, Brain : a journal of neurology.

[17]  D. Galasko,et al.  SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. , 2010, Archives of neurology.

[18]  Christian Wider,et al.  Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. , 2010, Archives of neurology.

[19]  L. Excoffier,et al.  Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows , 2010, Molecular ecology resources.

[20]  Eden R Martin,et al.  Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.

[21]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[22]  D. Ge,et al.  Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain , 2009, Human molecular genetics.

[23]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[24]  D. Berg,et al.  Genetic variability in the SNCA gene influences α‐synuclein levels in the blood and brain , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Eliezer,et al.  Residual structure, backbone dynamics, and interactions within the synuclein family. , 2007, Journal of molecular biology.

[26]  Walter A. Rocca,et al.  Beta-synuclein gene variants and Parkinson's disease: A preliminary case-control study , 2007, Neuroscience Letters.

[27]  E. Tolosa,et al.  A variable poly‐T sequence modulates α‐synuclein isoform expression and is associated with aging , 2007 .

[28]  Thomas Unger,et al.  Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s CT difference” formula , 2006, Journal of Molecular Medicine.

[29]  Aldo Quattrone,et al.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.

[30]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[31]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[32]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[33]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[34]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[35]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[36]  Sebastian Doniach,et al.  Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.

[37]  R. Nussbaum,et al.  Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. , 2001, Human molecular genetics.

[38]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[39]  J. Trojanowski,et al.  Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease , 2001, Brain Research.

[40]  Matthew J. Farrer,et al.  α-synuclein gene haplotypes are associated with Parkinson’s disease , 2001 .

[41]  A. Destée,et al.  No pathogenic mutations in the β-synuclein gene in Parkinson's disease , 1999, Neuroscience Letters.

[42]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[43]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[44]  H. Braak,et al.  Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[45]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[46]  A. Dehejia,et al.  Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. , 2001, Genome research.